Explore Our Comprehensive Life Sciences Industry Research Reports
P
2016
LAMEA Oncology/Anti-cancer Drugs Market is expected to reach $17,072.2 million by 2021, registering a CAGR of 8.6% during the forecast period 2015 - 2021. Oncology drugs are used ...
Report Code : A00719 | Pages : 108 | Category : Life Sciences
U
2022
Oncology drugs help in the prevention, diagnosis, and treatment of cancer. It includes chemotherapy drugs, hormone therapy drugs such as Tamoxifen (brand name Nolvadex), immunotherapy drugs, and other ...
Report Code : A02518 | Category : Life Sciences
U
2022
Oncology drugs include chemotherapy, hormone therapy, immunotherapy, and other drugs that are useful in the treatment of cancer. According to the CDC, 21.1 million adults were diagnosed with ...
Report Code : A02529 | Category : Life Sciences
P
2019
The China oncology drugs market was valued at $6,498.2 million in 2018 and is projected to reach $12,688.7 million by 2026, registering a CAGR of 8.7% from 2019 ...
Report Code : A04505 | Pages : 135 | Category : Life Sciences
P
2019
The Japan oncology drugs market size was accounted for $9,405 million in 2018, and is expected to reach $14,109 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.
Report Code : A05277 | Pages : 147 | Category : Life Sciences
A
2024
The report covers qualitative analysis, including drivers, opportunities, ...
Report Code : A127109 | Category : Life Sciences
P
2023
The current North America Metastatic Cancer Drugs Market is quantitatively analyzed from 2022 to 2032 to benchmark the financial competency.
Report Code : A132489 | Pages : 130 | Category : Life Sciences
P
2023
The U.S. Metastatic Cancer Drugs Market segment Distribution Channel is expected to witness highest CAGR during the forecast period. The report provides insights about opportunities that would help the market to expand in future.
Report Code : A132490 | Pages : 80 | Category : Life Sciences
P
2023
By end user, the Canada Metastatic Cancer Drugs Market market is bifurcated into various sectors, Of those, Distribution Channel was the largest segment and captured considerable market share in 2022.
Report Code : A132491 | Pages : 71 | Category : Life Sciences
P
2023
The report focuses on the major industry players operating in the Mexico Metastatic Cancer Drugs Market and their relative market share. Distribution Channel segment dominates the Mexico Metastatic Cancer Drugs Market and is expected to retain its dominance throughout the forecast period.
Report Code : A132492 | Pages : 75 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.